linkedin post 2013-04-09 16:28:53

Uncategorized
THE NIH, WHO, AND OTHER PRIVATE FOUNDATIONS ARE ADOPTING FOR-PROFIT MODELS, as have a number of Voluntary Health Organizations, as they fund the Valley Of Death for early stage therapeutics. This marks the beginning of the end of free money, which is not inappropriate in these times. If these groups can become more self-sustaining, the longer-term outlook may be improved. http://lnkd.in/nCJH8s View in LinkedIn
Read More

linkedin post 2013-04-12 05:02:54

Uncategorized
DENTISTRY STILL RELIES ON MECHANICAL SOLUTIONS TODAY. Overall, dentistry has changed little in a long time: drilling, scraping, pulling and gluing. This field is ripe for biological interventions. From biological interventions on gingivitis, enzymatic plaque removal, and to tooth buds, there are many possibilities to bring this discipline into the 21st century. View in LinkedIn
Read More

linkedin post 2013-04-11 06:22:35

Uncategorized
FAIR PRICING FOR RARE DISEASE DRUGS: two truths operate here. First, innovators must be incentivized. Second, prices are way out of line. One approach for consideration by pricing agencies is to take the sum an innovator invested, and set the return on investment in line with a mean of brand Pharma. That way benchmarks fairness to both the Pharma company and to patients. View in LinkedIn
Read More

linkedin post 2013-04-11 05:06:14

Uncategorized
PARTNERING WITH A BIG COMPANY REQUIRES SECURING AN INTERNAL CHAMPION. If you are presenting your technology with the aim of partnering, unless you can identify and get on your side (both) an internal champion with authority, the odds are you will fail. And in big companies, people often change responsibilities. I have seen many cases where the tech company secured a great champion, and late in the process the champion was reassigned and the whole dating game had to restart. That is rarely good news. http://lnkd.in/gxpS3A View in LinkedIn
Read More

linkedin post 2013-04-15 04:43:13

Uncategorized
AUTOLOGOUS BIOSKIN has been a field of active investigation especially for patients with severe burns. The approach is simple: take a sample of the patient's skin and culture it up in sheets suitable to cover the damaged skin. The main challenges have been to replicate the order of the sebaceous glands and the anatomic complexity of skin. It is probably only a matter of time until these issues are adequately resolved. View in LinkedIn
Read More